Urticaria - An update;Neues zur urtikaria

Allergologie

Volumn 27, Issue 11, 2004, Pages 435-443

  Wedi, Bettina ^a   Raap, U ^a   Wieczorek, D ^a   Kapp, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angioedema; Autoimmunity; Chronic urticaria; Helicobacter pylori; Infect; Molecular mimicry; Physical urticaria; Urticaria

Indexed keywords

AUTOIMMUNE DISEASE; DISEASE CLASSIFICATION; HUMAN; LABORATORY TEST; QUALITY OF LIFE; REVIEW; SKIN DISEASE; URTICARIA;

EID: 10344238563     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp27435     Document Type: Review

References (62)

1. Zuberbier T., W. Aberer, J. Grabbe et al.: Diagnostik und Therapie der Urtikaria. JDDG 1, 655-664 (2003).
2. Zuberbier T., M.W. Greaves, L. Juhlin et al : Definition, classification, and routine diagnosis of urticaria: a consensus report. J. Invest. Dermatol. Symp. Proc. 6, 123-127 (2001).
3. Hartmann K.: Urtikaria. Klassifikation und Diagnose. Hautarzt 55, 340-343 (2004).
4. Wedi B., T. Liekenbröcker, A. Kapp: Infektassoziation und Serumaktivität bei der chronischen Urtikaria - Ausdruck molekularer Mimikry? Allergologie 24, 480-490 (2001).
5. Raap U., T. Liekenbröcker, D. Wieczorek et al.: Neue Therapieoptionen der Urtikaria und ihrer Subtypen. Hautarzt 55, 361-366 (2004).
6. Asero R.: Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J. Allergy Clin. Immunol. 111, 1095-1098 (2003).
7. Maurer M., M. Metz, M. Margerl et al.: Autoreactive urticaria and autoimmune urticaria. Hautarzt 55, 350-356 (2004).
8. Baiardini I., A. Giardini, M. Pasquali et al.: Quality of life and patients satisfaction in chronic urticaria and respiratory allergy. Allergy 58, 621-623 (2003).
9. Poon E., P.T. Seed, M.W. Greaves, A. Kobza-Black: The extent and nature of disability in different urticarial conditions. Br. J. Dermatol. 140, 667-671 (1999).
10. Wedi B., A. Kapp: Helicobacter pylori infection in skin diseases: a critical appraisal. Am. J. Clin. Dermatol. 3, 273-282 (2002).
11. Wedi B., U. Raap, A. Kapp: Chronic urticaria and infections. Curr. Opin. Allergy Clin. Immunol. 4, 387-396 (2004).
12. Wedi B.: Akute, chronische und physikalische Urtikaria. Wo kommen die Quaddeln her? MMW Fortschr. Med. 10, 28-32 (2002).
13. Wedi B., V. Novacovic, M. Koerner, A. Kapp: Chronic urticaria is frequently triggered by focal, particularly gastrointestinal infection: analysis of 325 cases. J. Invest. Dermatol. Symp. Proc. 6, 163 (2001).
14. Wedi B., S. Wagner, T. Werfel et al.: Rationelles diagnostisches Vorgehen bei der chronischen Urtikaria. Z. Hautkr. 75, 78-84 (2000).
15. Wedi B., S. Wagner, T. Werfel et al.: Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int. Arch. Allergy Immunol. 116, 288-294 (1998).
16. Bakos N., B. Fekete, Z. Prohaszka et al.: High prevalence of IgG and IgA antibodies to 19 kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy 58, 663-667 (2003).
17. Hidvegi B., R. Gonzalez-Cabello, E. Temesvari et al.: The effect of heat-inactivated Helicobacter pylori on the blastogenic response of peripheral blood mononuclear cells of patients with chronic urticaria. Int. Arch. Allergy Immunol. 126, 167-172 (2001).
18. Varvarovska J., J. Sykora, F. Stozicky, I. Chytra: Acquired angioedema and Helicobacter pylori infection in a child. Eur. J. Pediatr. 162, 707-709 (2003).
19. Farkas H., L. Gyeney, P. Majthenyi et al.: Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z. Gastroenterol. 37, 513-518 (1999).
20. Greaves M.: Autoimmune urticaria. Clin. Rev. Allergy Immunol. 23, 171-183 (2002).
21. Kleine-Tebbe J., M. Sticherling, U.-F. Haustein: Autoimmun-Urtikaria: chronisch rezidivierende Urtikaria durch autoreaktive Antikörper. Allergologie 24, 463-474 (2001).
22. Malmros H.: Autoserumtest. Nordisk Med. 29, 150-151 (1946).
23. Ferrer M., E. Luquin, A. Sanchez-Ibarrola et al.: Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int. Arch. Allergy Immunol. 129, 254-260 (2002).
24. Sabroe R.A., E. Poon, G.E. Orchard et al.: Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies. J. Allergy Clin. Immunol. 103, 484-493 (1999).
25. Caproni M., W. Volpi, D. Macchia et al.: Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp. Dermatol. 12, 621-628 (2003).
26. Mari A.: Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int. Arch. Allergy Immunol. 133, 29-39 (2004).
27. Sabroe R.A., E. Fiebiger, D.M. Francis et al.: Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J. Allergy Clin. Immunol. 110, 492-499 (2002).
28. Kikuchi Y., A.P. Kaplan: Mechanisms of autoimmune activation of basophils in chronic urticaria. J. Allergy Clin. Immunol. 107, 1056-1062 (2001).
29. Asero R., A. Tedeschi, M. Lorini et al.: Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors. Int. Arch. Allergy Immunol. 131, 195-200 (2003).
30. Sabroe R.A., D.M. Francis, R.M. Barr et al.: Anti-Fc(epsilon)RI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J. Allergy Clin. Immunol. 102, 651-658 (2001).
31. Wedi B., V. Novacovic, M. Koerner, A. Kapp: Chronic urticaria serum induces histamine release, leukotriene production and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs. J. Allergy Clin. Immunol. 105, 552-560 (2000).
32. Levy Y., N. Segal, N. Weintrob, Y.L. Danon: Chronic urticaria: association with thyroid autoimmunity. Arch. Dis. Child. 88, 517-519 (2003).
33. Zauli D., A. Grassi, G. Ballardini et al.: Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am. J. Clin. Dermatol. 3, 525-528 (2002).
34. Asero R.: Sex differences in the pathogenesis of chronic urticaria. J. Allergy Clin. Immunol. 111, 425-426 (2003).
35. Kandeel A.A., M. Zeid, T. Helm et al.: Evaluation of chronic urticaria in patients with Hashimoto thyroiditis. J. Clin. Immunol. 21, 335-347 (2001).
36. Liekenbröcker T., M. Koerner, A. Kapp, B. Wedi: Korrelation der infektassoziierten chronischen Urtikaria mit positivem autologem Serumtest. Allergologie 24, 475-479 (2001).
37. Hizal M., B. Tuzun, R. Wolf, Y. Tuzun: The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int. J. Dermatol. 39, 443-445 (2000).
38. Bakos N., M. Hillander: Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int. J. Dermatol. 42, 613-615 (2003).
39. Greaves M. W.: Pathophysiology of chronic urticaria. Int. Arch. Allergy Immunol. 127, 3-9 (2002).
40. Grattan C.E., D. Walpole, D.M. Francis et al.: Flow-cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine-releasing activity. Clin. Exp. Allergy 27, 1417-1424 (1997).
41. Grattan C.E., G. Dawn, S. Gibbs, M.M. Francis: Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin. Exp. Allergy 33, 337-341 (2003).
42. Hidvegi B., E. Nagy, T. Szabo et al.: Correlation between T cell and mast cell activity in patients with chronic urticaria. Int. Arch. Allergy Immunol. 132, 177-182 (2003).
43. Toubi E., A. Adir-Shani, A. Kessel et al.: Immune abberations in B and T lymphocytes derived from chronic urticaria patients. J. Clin. Immunol. 20, 371-378 (2000).
44. Asero R., A. Tedeschi, M. Lorini et al.: Circulating stem cell factor in patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol. 91, 79-81 (2003).
45. Nettis E., A. Pannofino, C. DAprile et al.: Clinical and aetiological aspects in urticaria and angioedema. Br. J. Dermatol. 148, 501-506 (2003).
46. Juhlin L.: Alternative treatments for severely affected patients with urticaria. J. Invest. Dermatol. Symp. Proc. 6, 157-159 (2001).
47. Zuberbier T., J. Ifflander, C. Semmler, B.M. Henz: Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm. Venereol. 76, 295-297 (1996).
48. Reimers A,. C. Pichler, A. Helbling et al.: Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin. Exp. Allergy 32, 1763-1768 (2002).
49. Bagenstose S.E., L. Levin, J.A. Bernstein: The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J. Allergy Clin. Immunol. 113, 134-140 (2004).
50. Boehncke W.H., R.J. Ludwig, T.M. Zollner et al.: The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. Br. J. Dermatol. 148, 604-606 (2003).
51. Grattan C.E., B.F. ODonnell, D.M. Francis et al.: Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br. J. Dermatol. 143, 365-372 (2000).
52. ODonnell B.F., R.M. Barr, A.K. Black et al.: Intravenous immunoglobulin in autoimmune chronic urticaria. Br. J. Dermatol. 138, 101-106 (1998).
53. Grattan C.E.H., D.M. Francis, N.G.P. Slater et al.: Plasmapheresis for severe, unremitting, chronic urticaria. Allerg. Immunol. (Paris) 339, 1078-1080 (1992).
54. Tedeschi A., L. Airaghi, M. Lorini, R. Asero: Chronic urticaria: a role for newer immunomodulatory drugs? Am. J. Clin. Dermatol. 4, 297-305 (2003).
55. Merk H.F.: Therapie der chronischen Urtikaria (Treatment of chronic urticaria). Allergologie 24, 491-502 (2001).
56. Dawn G., M. Urcelay, A. Ah-Weng et al.: Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria. Br. J. Dermatol. 149, 836-840 (2003).
57. Gach J.E., R.A. Sabroe, M.W. Greaves, A. Kobza-Black: Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br. J. Dermatol. 145, 340-343 (2001).
58. Johnstone R.F., W.K. Dolen, H.M. Hoffman: A large kindred with familial cold autoinflammatory syndrome. Ann. Allergy Asthma Immunol. 90, 233-237 (2003).
59. Bork K., J. Hardt, K.H. Schicketanz, N. Ressel: Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch. Intern. Med. 163, 1229-1235 (2003).
60. Dean D.E., D.L. Schultz, R.H. Powers: Asphyxia due to angiotensin-converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J. Forens. Sci. 46, 1239-1243 (2001).
61. Adam A., M. Cugno, G. Molinaro et al.: Amino-peptidase P in individuals with a history of angioedema on ACE inhibitors. Allerg. Immunol. (Paris) 359, 2088-2089 (2002).
62. Gavras I.: Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers? Arch. Intern. Med. 163, 240-241 (2003).